文献速递治疗药物监测与药物基因组学特殊人群用药

土豆来源茄啶作为膳食CYP2D6生物标志物的证据:与利培酮代谢显著相关

Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism.
PubMed 文献 · Br J Clin Pharmacol · 2023-04-11

本研究利用229例已知CYP2D6基因型并接受利培酮治疗患者的治疗药物监测数据,半定量测定茄啶及其5种代谢物,分析其代谢比与9-羟利培酮/利培酮比值的相关性。

要点

  • 茄啶代谢比与CYP2D6介导的利培酮代谢呈高度显著正相关。
  • CYP2D6功能正常者中M444/茄啶代谢比相关性最强(ρ0.72-0.77)。
  • 茄啶代谢有望作为CYP2D6表型生物标志物辅助个体化给药。

核心结论

  • 茄啶代谢与CYP2D6介导的利培酮代谢呈强正相关,提示茄啶代谢可能预测个体CYP2D6代谢。

研究设计与样本

  • 纳入229例已知CYP2D6基因型并接受利培酮治疗患者的治疗药物监测数据。
  • 利用TDM全扫描高分辨率质谱文件重新处理,半定量测定茄啶及5种代谢物(M402、M414、M416、M440、M444)。
  • 采用Spearman检验分析茄啶代谢比与9-羟利培酮/利培酮比值的相关性。

临床怎么用

  • 对于已知CYP2D6基因型的患者,茄啶代谢比可能辅助预测CYP2D6代谢表型。
  • 茄啶代谢标志物有望用于优化经CYP2D6代谢药物的个体化剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The extensive variability in cytochrome P450 2D6 (CYP2D6) metabolism is mainly caused by genetic polymorphisms. However, there is large, unexplained variability in CYP2D6 metabolism within CYP2D6 genotype subgroups. Solanidine, a dietary compound found in potatoes, is a promising phenotype biomarker predicting individual CYP2D6 metabolism. The aim of this study was to investigate the correlation between solanidine metabolism and the CYP2D6-mediated metabolism of risperidone in patients with known CYP2D6 genotypes. METHODS: The study included therapeutic drug monitoring (TDM) data from CYP2D6-genotyped patients treated with risperidone. Risperidone and 9-hydroxyrisperidone levels were determined during TDM, and reprocessing of the respective TDM full-scan high-resolution mass spectrometry files was applied for semi-quantitative measurements of solanidine and five metabolites (M402, M414, M416, M440 and M444). Spearman's tests determined the correlations between solanidine metabolic ratios (MRs) and the 9-hydroxyrisperidone-to-risperidone ratio. RESULTS: A total of 229 patients were included. Highly significant, positive correlationswere observed between all solanidine MRs and the 9-hydroxyrisperidone-to-risperidone ratio (ρ > 0.6, P < .0001). The strongest correlation was observed for the M444-to-solanidine MR in patients with functional CYP2D6 metabolism, i.e., genotype activity scores of 1 and 1.5 (ρ 0.72-0.77, P < .0001). CONCLUSION: The present study shows strong, positive correlations between solanidine metabolism and CYP2D6-mediated risperidone metabolism. The strong correlation within patients carrying CYP2D6 genotypes encoding functional CYP2D6 metabolism suggests that solanidine metabolism may predict individual CYP2D6 metabolism, and hence potentially improve personalized dosing of drugs metabolized by CYP2D6.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wollmann BM, Smith RL, Kringen MK, et al. Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism. Br J Clin Pharmacol. 2023. PMID: 36960588. doi:10.1111/bcp.15721

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。